Skip to main content
. 2020 Apr 24;3:193. doi: 10.1038/s42003-020-0933-1

Fig. 3. KH-3 inhibits breast cancer cell growth and destabilizes HuR targets.

Fig. 3

a, b MTT-based cytotoxicity of KH-3 against a panel of TNBC cell lines (a) and MDA-MB-231 cells, sgControl and two HuR KO clones (b). ch Half-life of Bcl-2, Msi2 and XIAP mRNA in MDA-MB-231 (ce) and SUM159 (fh) cells treated with 5 μg/mL actinomycin D together with DMSO, KH-3 or KH-3B. Data are mean ± SD from n = 3 independent experiments (*P < 0.05, **P < 0.01, ***P < 0.001, two-way ANOVA).